Santhosh Satapati
Senior Director, Metabolic Diseases Insitro
Seminars
Thursday 17th September 2026
Panel Discussion: Defining The Future Mash Treatment Landscape To Prioritize Differentiated Therapies, Optimize Combination Strategies & Establish Long-Term Standards Of Care
3:30 pm
- Defining future standards of care across fibrosis, metabolic dysfunction and advanced disease populations to prioritize differentiated therapies, improving long-term clinical and commercial positioning
- Evaluating how combination strategies and emerging mechanisms will shape the post-Rezdiffra treatment landscape to optimize development planning, enabling stronger therapeutic differentiation and improved patient outcomes
- Identifying the clinical, regulatory and competitive factors that will determine best-in-class therapies to strengthen late-stage development strategies, improving adoption potential and long-term market success
Wednesday 16th September 2026
Integrating AI/Ml With Disease Biology To Identify Differentiated Novel Mash Targets
10:30 am
- Leveraging multi-modal patient data and AI to discover relevant pathways improving target prioritization and accelerating development decision-making
- “Integrating AI/ML with high-dimensional assays to discover novel targets” Leveraging deep biological datasets to build differentiated strategies and maximize translational confidence
- Applying machine learning-enabled discovery strategies to improve therapeutic precision, strengthening pipeline differentiation and increasing future clinical success potential
